NRx Pharmaceuticals Inc. (NASDAQ:NRXP) trading with an addition of $2.98 to $12.42 on Thursday, an upside of 31.57 percent. An average of 8,428,514 shares of common stock have been traded in the last five days. There was a gain of $3.80 in the past week, and it reached a new high 15 times over the past 12 months. The last 20 days have seen an average of 2,888,533 shares traded, while the 50-day average volume stands at 2,484,879.
NRXP stock has decreased by -25.32% in the last month. The company shares reached their 1-month lowest point of $6.43 on 10/11/21. With the stock rallying to its 52-week high on 02/02/21, shares of the company touched a low of $6.43 and a high of $76.99 in 52 weeks. It has reached a new high 9 times so far this year and lost -61.31% or -$12.81 in price. In spite of this, the price is down -83.87% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
NRx Pharmaceuticals Inc. (NRXP) has a trailing price-to-earnings (P/E) ratio of 34.65 for the broader industry and 32.79 for the sector. The stock’s beta is 0.25. The quick ratio of NRx Pharmaceuticals Inc. for the recent quarter was 0.50, and the current ratio was 0.50, indicating that the company is not able to meet its debt obligations.
In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$271.83 million in the quarter, while revenues of -$0.89 million were grew 100.0%. For the quarter, EBITDA amounted to -$17.12 million. Shareholders own equity worth $48.6 million.
From a technical analysis perspective, let’s take a brief look at NRx Pharmaceuticals Inc. (NRXP) price momentum. RSI 9-day as of the close on 13 October was 61.17%, suggesting the stock is Neutral, with historical volatility in this time frame at 292.66%.
As of today, NRXP’s price is $9.14 +48.78% or $3.80 from its 5-day moving average. NRXP is currently trading +10.38% higher than its 20-day SMA and -52.21% lower than its 100-day SMA. However, the stock’s current price level is -20.94% below the SMA50 and -63.74% below the SMA200.
The stochastic %K and %D were 81.43% and 57.45%, respectively, and the average true range (ATR) was 1.57. With the 14-day stochastic at 85.02% and the average true range at 1.49, the RSI (14) stands at 55.34%. The stock has reached 1.77 on the 9-day MACD Oscillator while the 14-day reading was at 1.59.
The consensus rating for NRx Pharmaceuticals Inc. (NRXP) among analysts is -. According to current brokerage recommendations, 0 brokerage firms advise that investors sell NRXP, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 0 others rate it as a “buy”.